Safety and efficacy of bridging to lung transplantation with antifibrotic drugs in idiopathic pulmonary fibrosis: a case series.
Isabelle DelanoteWim A WuytsJonas YserbytEric K VerbekenGeert M VerledenRobin VosPublished in: BMC pulmonary medicine (2016)
Antifibrotic drugs can probably be safely administered in IPF patients, possibly attenuating disease progression over time, while awaiting LTx.